SCHEMBL18201260

SCHEMBL18201260

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4nc5ccccc5c5c4cc(-c4cccc6ccccc46)c4ccccc45)c3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ATM Q13315 2/20 0.42
KDM4E B2RXH2 2/20 0.42
TP53 P04637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PDE5A O76074 4/20 0.37
ABCG2 Q9UNQ0 7/20 0.37
WHR1 P49842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200661 0.94 MEN1 (0.49) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL18200944 0.89 MEN1 (0.46) MEN1KMT2AATMALDH1A1MAPK1
SCHEMBL18200668 0.89 MEN1 (0.46) MEN1KMT2AATMALDH1A1MAPK1
SCHEMBL18200945 0.89 MEN1 (0.46) MEN1KMT2AATMALDH1A1MAPK1
SCHEMBL17035003 0.89 MEN1 (0.44) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL18201258 0.88 MEN1 (0.48) MEN1KMT2AMAPTATMALDH1A1
SCHEMBL17034999 0.87 MEN1 (0.49) MEN1KMT2AMAPTATMKDM4E
SCHEMBL18200542 0.86 ALDH1A1 (0.37) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL18200332 0.85 MEN1 (0.51) MEN1KMT2AMAPTATMKDM4E
SCHEMBL18200348 0.85 MEN1 (0.43) MEN1KMT2ASMN1; SMN2ATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MEN1 1750/4885KMT2A 1104/4885MAPT 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.